These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27785139)

  • 1. Selected metabolic aspects of elastin and collagen fiber proteolysis in diseases of the respiratory system - the significance of α1 antitrypsin deficiency.
    Dżeljilji A; Rokicki W; Karuś K
    Kardiochir Torakochirurgia Pol; 2016 Sep; 13(3):242-247. PubMed ID: 27785139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic and clinical aspects of the alpha1-antitrypsin.
    Talamo RC
    Pediatrics; 1975 Jul; 56(1):91-9. PubMed ID: 1099521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.
    Petrache I; Fijalkowska I; Zhen L; Medler TR; Brown E; Cruz P; Choe KH; Taraseviciene-Stewart L; Scerbavicius R; Shapiro L; Zhang B; Song S; Hicklin D; Voelkel NF; Flotte T; Tuder RM
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1222-8. PubMed ID: 16514110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha one antitrypsin deficiency: from gene to treatment.
    Wood AM; Stockley RA
    Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.
    Cosio MG; Bazzan E; Rigobello C; Tinè M; Turato G; Baraldo S; Saetta M
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S305-10. PubMed ID: 27564665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emphysema: looking beyond alpha-1 antitrypsin deficiency.
    Janssen R; Piscaer I; Franssen FME; Wouters EFM
    Expert Rev Respir Med; 2019 Apr; 13(4):381-397. PubMed ID: 30761929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.
    Gadek JE; Fells GA; Zimmerman RL; Rennard SI; Crystal RG
    J Clin Invest; 1981 Oct; 68(4):889-98. PubMed ID: 6169740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
    Carrell RW
    COPD; 2004 Apr; 1(1):71-84. PubMed ID: 16997740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two sisters with lung emphysema].
    Piscaer I; Franssen FM; Ten Hacken NH; Wouters EF; Janssen R
    Ned Tijdschr Geneeskd; 2016; 160():D497. PubMed ID: 27879179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 Antitrypsin Deficiency Today: New Insights in the Immunological Pathways.
    Baraldo S; Balestro E; Bazzan E; Tiné ME; Biondini D; Turato G; Cosio MG; Saetta M
    Respiration; 2016; 91(5):380-5. PubMed ID: 27164860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
    Kuhn C
    J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale.
    Janssen R; Wouters EF; Janssens W; Daamen WF; Hagedoorn P; de Wit HA; Serré J; Gayan-Ramirez G; Franssen FM; Reynaert NL; von der Thüsen JH; Frijlink HW
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2587-2602. PubMed ID: 32063701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations of inflammatory mediators and alpha1-antitrypsin levels after lung volume reduction surgery for emphysema.
    Mineo D; Ambrogi V; Cufari ME; Gambardella S; Pignotti L; Pompeo E; Mineo TC
    Am J Respir Crit Care Med; 2010 Apr; 181(8):806-14. PubMed ID: 20056899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage.
    Luisetti M; Piccioni PD; Donnetta AM; Bulgheroni A; Peona V
    Respiration; 1992; 59 Suppl 1():24-7. PubMed ID: 1579728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
    de Santi MM; Martorana PA; Cavarra E; Lungarella G
    Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.